Anti-thrombotic effect of milrinone is caused by inhibition of calcium release from the dense tubular system in human platelets

Acta Anaesthesiologica Scandinavica

Volumn 47, Issue 1, 2003, Pages 53-57

  Hiramatsu, Noriko ^a   Kageyama, K ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Calcium; Milrinone; Platelet aggregation

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM CHANNEL; CYCLIC AMP; FLUORESCENT DYE; MILRINONE; PHOSPHODIESTERASE INHIBITOR;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART MUSCLE; HUMAN; HUMAN EXPERIMENT; INOTROPISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; BLOOD PLATELETS; CALCIUM; CALCIUM CHLORIDE; DATA INTERPRETATION, STATISTICAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MANGANESE; MICROTUBULES; MILRINONE; NICKEL; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SPECTROMETRY, FLUORESCENCE;

EID: 0037227760     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2003.470109.x     Document Type: Article

References (30)

1. Butterworth JF, 4th Hines RL, Royster RI, James RL. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg 1995: 81: 783-792.
2. Bailey JM, Levy JH, Kikura M, Szlam F, Hug CC Jr. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology 1994: 81: 616-622.
3. Ronald AY, Alan W. Milrinone: A preliminary review of its pharmacological properties and therapeutic use. Drugs 1988: 36: 158-192.
4. Alousi AA, Stankus GP, Stuart JC, Walton LH. Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species. J Cardiovasc Pharmacol 1983: 5: 804-811.
5. Pattison A, Astley N, Eason CT, Bonner FW. A comparison of the effects of three positive inotropic agents (amrinone, milrinone and medorinone) on platelet aggregation in human whole blood. Thromb Res 1990: 57: 909-918.
6. Haynes DH. Effects of cyclic nucleotides and protein kinases on platelet calcium homeostasis and mobilization. Platelets 1993: 4: 231-242.
7. Lagarde M, Bryon PA, Guichardant M, Dechavanne M. A simple and efficient method for platelet isolation from their plasma. Thromb Res 1980: 17: 581-588.
8. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol (Lond) 1963: 168: 178-195.
9. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985: 260: 3440-3450.
10. Himpens B, Somlyo AP. Free-calcium and force transients during depolarization and pharmacomechanical coupling in guinea-pig smooth muscle. J Physiol (Lond) 1988: 395: 507-530.
11. Sato K, Ozaki H, Karaki H. Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2. J Pharmacol Exp Ther 1988: 246: 294-300.
12. Tsien RY, Rink TJ, Poenie M. Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium 1985: 6: 145-157.
13. Merritt JE, Jacob R, Hallam TJ. Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 1989: 264: 1522-1527.
14. Hallam TJ, Rink TJ. Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett 1985: 186: 175-179.
15. Hallam TJ, Rink TJ. Insights into platelet function gained with fluorescent indicators. In: MacIntyre DE, Gordon JL, eds. Platelets in Biology and Pathology III. New York, NY: Elsevier Inc, 1987: 353-372.
16. Hidaka H, Asano T. Human blood platelet-3′: 5′-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase. Biochim Biophys Acta 1976: 429: 485-497.
17. Yada Y, Nagao S, Okano Y, Nozawa Y. Inhibition by cyclic AMP of guanine nuclotide-induced activation of phosphoinositide-specific phospholipase C in human platelets. FEBS Lett 1989: 242: 368-372.
18. Cone J, Wang S, Tandon N et al. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovasc Pharmacol 1999: 34: 497-504.
19. Watson SP, McConnell RT, Lapetina EG. The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. J Biol Chem 1984: 259: 13199-13203.
20. Käser-Glanzmann R, Jakábová M, George JN, Lüscher EF. Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′, 5′-cyclic monophosphate and protein kinase. Biochim Biophys Acta 1977: 466: 429-440.
21. Enouf J, Giraud F, Bredoux R, Bourdeau N, Levy-Toledano S. Possible role of a cAMP-dependent phosphorylation in the calcium release mediated by inositol 1, 4, 5-triphosphate in human platelet membrane vesicles. Biochim Biophys Acta 1987: 928: 76-82.
22. O'Rourke FA, Halenda SP, Zavoico GB, Feinstein MB. Inositol 1, 4, 5-triphosphate releases Ca2+ from a Ca2+-transporting membrane vesicle fraction derived from human platelets. J Biol Chem 1985: 260: 956-962.
23. Brass LF, Joseph SK. A role for inositol triphosphate in intracellular Ca2+ mobilization and granule secretion in platelets. J Biol Chem 1985: 260: 15172-15179.
24. Uemura Y, Sakon M, Kambayashi J, Tsujinaka T, Mori T. Involvement of inositol 1, 4, 5-triphosphate in Ca2+ influx in thrombin stimulated human platelets. Biochem Int 1989: 18: 335-341.
25. 1, amrinone and milrinone on platelet aggregation in human whole blood. Platelets 2000: 11: 446-458.
26. Roevens P, Courcelles DC. Cyclic AMP-phosphodiesterase IIIA1 inhibitors decrease cytosolic Ca2+ concentration and increase the Ca2+ content of intracellular stage sites in human platelets. Biochem Pharmacol 1993: 45: 2279-2282.
27. Anderson JL, Baim DS, Fein SA, Goldstein RAL, Ejemtel TH, Likoff MJ. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: A multicenter study. J Am Coll Cardiol 1987: 9: 711-722.
28. Aoki H, Mizobe T, Nozuchi S, Hiramatsu N. In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation. Anesthesiology 1998: 88: 362-370.
29. Aoki H, Inoue M, Mizobe T, Harada M, Imai H, Kobayashi A. Platelet function is inhibited by nitric oxide liberation during nitroglycerin-induced hypotension anaesthesia. Br J Anaesth 1997: 79: 476-481.
30. Nozuchi S, Mizobe T, Aoki H et al. Sevoflurane does not inhibit human platelet aggregation induced by thrombin. Anesthesiology 2000: 92: 164-170.